We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MDS Pharma Services, a provider of innovative drug discovery and development
solutions, is the first contract research organization to adopt the new API
5000 mass spectrometer for small molecule quantification studies.
Syneron Medical and its North American subsidiary
Syneron, an innovator in the development, marketing and sales of ELOS combined-energy
medical aesthetic devices, have announced that in a recent meeting between senior
company officials and representatives of the FDA, the FDA representatives stated
it appears reasonable for Syneron to submit a 510(k) premarket notification
to the FDA for marketing clearance of its VelaSmooth system in the U.S.
Radi Medical Systems, a designer and manufacturer of innovative devices in interventional
cardiology, has announced the 510(k) clearance of the RadiAnalyzerXpress.
Imaging Sciences International, a developer and manufacturer of advanced dental
and maxillofacial radiography products, has announced that the International
Organization for Standardization (ISO) has awarded ISO 9001:2000 and ISO 13485:2003
certifications to the company.
Biophan Technologies has been issued two new patents by the U.S. Patent and
Trademark Office that extend the company's competitive edge in the marketplace
for the rapidly emerging field of magnetic resonance imaging (MRI) safety and
image compatibility for medical instruments and implanted devices.
Framingham-Mass. based Transport Pharmaceuticals signed a license and collaboration
agreement with pharmaceutical giant GlaxoSmithKline for Transport's iontophoretic
device/drug combination system for the delivery of acyclovir, an approved cold-sore
(herpes labialis) treatment.
Bracco Diagnostics, which develops and manufactures a number of radiology, radiopharmaceutical
and other diagnostic imaging products, and Amerinet, one of the leading health
care group purchasing organizations in the U.S., have announced the inclusion
of MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, into the companies'
previously established product purchasing agreement.
Resonance Health has announced that its subsidiary, Inner Vision Biometrics,
achieved FDA marketing approval for FerriScan, its novel noninvasive diagnostic
test for liver iron concentration.